IR Contact

Poseida Therapeutics Virtual R&D Day

February 23, 2022
Click here to watch the replay.

Investor contact: 
Alex Lobo
Stern Investor Relations
Alex.lobo@sternir.com 

Media contact:
Sarah Thailing
Senior Director, Corporate Communications and IR
Poseida Therapeutics, Inc. 
858-605-3717
sthailing@poseida.com